High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
Clinical trial NCT01266603 · COMPLETED
Trial details
- NCT number
- NCT01266603
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-22
- Primary completion
- 2018-11-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.